AR078393A1 - Inhibicion de la formacion de adhesiones en los tendones - Google Patents

Inhibicion de la formacion de adhesiones en los tendones

Info

Publication number
AR078393A1
AR078393A1 ARP100103400A ARP100103400A AR078393A1 AR 078393 A1 AR078393 A1 AR 078393A1 AR P100103400 A ARP100103400 A AR P100103400A AR P100103400 A ARP100103400 A AR P100103400A AR 078393 A1 AR078393 A1 AR 078393A1
Authority
AR
Argentina
Prior art keywords
composition according
formation
adhesions
tendons
inhibition
Prior art date
Application number
ARP100103400A
Other languages
English (en)
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of AR078393A1 publication Critical patent/AR078393A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

Una composicion que tiene una osmolaridad de al menos 1.200mOsmol para utilizar como un medicamento para inhibir la formacion de adhesiones en los tendones. Las composiciones pueden comprender un fosfato de azucar, tal como manosa-6-fosfato (M6P) y/o glucosa-6-fosfato (G6P). Las composiciones que comprenden M6P son particularmente favoritas. Reivindicacion 16: Una composicion de acuerdo con cualquiera de las reivindicaciones precedentes, para administracion epitendinosa. Reivindicacion 17: Una composicion de acuerdo con cualquiera de las reivindicaciones precedentes, para administracion intratendinosa. Reivindicacion 18: Una composicion de acuerdo con cualquiera de las reivindicaciones precedentes, para administrar antes de una lesion. Reivindicacion 19: Una composicion de acuerdo con cualquiera de las reivindicaciones precedentes, para administrar a una lesion existente.
ARP100103400A 2009-09-17 2010-09-17 Inhibicion de la formacion de adhesiones en los tendones AR078393A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0916334.6A GB0916334D0 (en) 2009-09-17 2009-09-17 Inhibition of tendon adhesions

Publications (1)

Publication Number Publication Date
AR078393A1 true AR078393A1 (es) 2011-11-02

Family

ID=41277878

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103400A AR078393A1 (es) 2009-09-17 2010-09-17 Inhibicion de la formacion de adhesiones en los tendones

Country Status (4)

Country Link
AR (1) AR078393A1 (es)
GB (1) GB0916334D0 (es)
TW (1) TW201114429A (es)
WO (1) WO2011033306A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9427186B2 (en) 2009-12-04 2016-08-30 Endomagnetics Ltd. Magnetic probe apparatus
US10634741B2 (en) 2009-12-04 2020-04-28 Endomagnetics Ltd. Magnetic probe apparatus
CA2904779C (en) 2013-03-11 2019-04-09 Endomagnetics Ltd. Hypoosmotic solutions for lymph node detection
US9239314B2 (en) 2013-03-13 2016-01-19 Endomagnetics Ltd. Magnetic detector
US9234877B2 (en) 2013-03-13 2016-01-12 Endomagnetics Ltd. Magnetic detector
EP3302338B1 (en) 2015-06-04 2020-09-30 Endomagnetics Ltd. Marker materials and forms for magnetic marker localization

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9516012D0 (en) 1995-08-04 1995-10-04 Univ Manchester Pharmaceutical composition
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders

Also Published As

Publication number Publication date
WO2011033306A1 (en) 2011-03-24
GB0916334D0 (en) 2009-10-28
TW201114429A (en) 2011-05-01

Similar Documents

Publication Publication Date Title
AR078393A1 (es) Inhibicion de la formacion de adhesiones en los tendones
BRPI1009842B8 (pt) uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas
CO6331301A2 (es) Combinaciones y metodos para administracion subcutanea de inmunoglobulina y hialuronidasa
BR112013002601A2 (pt) corticosteróides para o tratamento de dor em articulação
BR112012010706A2 (pt) composto, composição farmacêutica, combinação do produto farmacêutico, uso de um composto, e, métodos para o tratamento de uma doença ou condição, e para inibir um bromodomínio
DOP2013000105A (es) Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis
CL2011000306A1 (es) Compuestos derivados de di-alquilamida del acido 7-ciclopentil-2-[5-(piperidin o piperazin sustituido)-piridin-2-il amino]-7h-pirrolo-[2,3-d]-pirimidin-6-carboxilico, inhibidores de cdk4; composicion farmaceutica; y su uso para el tratamiento del cancer o la inflamacion.
UY32989A (es) Coposiciones terapéuticas concentradas de fosfolípidos
BRPI0709581A8 (pt) compostos de bicicloeteroarila como moduladores de px27 e seu uso
CO6470821A2 (es) Pirazinilpirazoles
BR112015029240A2 (pt) composto, composição e método de evitar ou tratar inflamação associada com inflamassoma nrlp3 em um indivíduo
UY32359A (es) Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
EA201370006A1 (ru) Местная фармацевтическая композиция, содержащая флурбипрофен
BR112014007376A2 (pt) método de proporcionar por via oral uma substância bioativa a um indivíduo em necessidade da mesma, forma de dosagem oral e composição de dosagem oral
BRPI0924617A8 (pt) Compostos heterociclicos de fenoximetila
BR112013003658A2 (pt) compostos antivirais contendo azida
BR112014020271A8 (pt) Composição farmacêutica e métodos para diminuir a frequência de micção em paciente
NI201300045A (es) Inhibidores de apoptosis y usos de los mismos.
UY31325A1 (es) Composiciones y métodos para tratar enfermedades y trastornos inmunologicos e inflamatorios
CO6280488A2 (es) Combinacion farmaceutica
BR112015022196A2 (pt) composições de liberação prolongada, que compreendem hidrocodona e acetaminofeno para rápido início e analgesia prolongada, que podem ser administradas independentemente de alimentos
BR112012022209A2 (pt) composições farmacêuticas compreendendo monoterpenos
SV2011003839A (es) Agentes antifungicos
MA32416B1 (fr) 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation

Legal Events

Date Code Title Description
FB Suspension of granting procedure